secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2025-08-01T23:59:59+00:00
Accession:  0001558370-25-009933
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iradimed reports record Q2 revenue of $20.4M (+14% YoY), raises FY2025 guidance
-------------------------------------------------------------------------------

- GAAP diluted EPS of $0.45 (up 18% YoY); non-GAAP diluted EPS of $0.49 (up 17% YoY).
- Declares regular quarterly cash dividend of $0.17 per share, payable Aug 28, 2025.
- FY2025 revenue guidance raised to $80-82.5M; GAAP EPS to $1.60-1.70; non-GAAP EPS to $1.76-1.86.
- Gross profit margin held at 78%; record backlog for pump and monitor products as of June 30, 2025.
- Q3 2025 guidance: revenue $20.5-20.9M, GAAP EPS $0.41-0.45, non-GAAP EPS $0.45-0.49.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000155837025009933/0001558370-25-009933-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000155837025009933/irmd-20250801x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-009933

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer